The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is investing $250,000 into a developer of structural heart repair technologies, Micro Interventional Devices (MID).
MID has developed an initial product, a minimally invasive device called Permaseal, which provides access and wound closure during structural heart repair procedures.
MID said the Permaseal moves with in the beating heart, while still keeps the edges of the wound closed.
The Permaseal device not only enables wound healing without the use of sutures, but it is cost- and time-efficient.
Micro Interventional Devices president & CEO Michael Whitman said the Permaseal access and closure device will enable unprecedented safe and reliable transmyocardial access for structural heart repair procedures.